Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims
The vast majority of deliveries had confirmatory evidence regardless of apparent setting. Patient characteristics differed by delivery setting. Inclusion of apparent outpatient deliveries may increase the sample size of the study population and improve the generalizability of study results.
Authors
- Sarah S. Osmundson (ORCID: https://orcid.org/0000-0002-7626-9992)
- Sascha Dublin (ORCID: https://orcid.org/0000-0002-6649-3659)
- Katelin B. Nickel (ORCID: https://orcid.org/0000-0003-4116-512X)
- Anne M. Butler (ORCID: https://orcid.org/0000-0001-7307-6864)
- Mollie E. Wood (ORCID: https://orcid.org/0000-0002-9302-2641)
- Elizabeth A. Suarez (ORCID: https://orcid.org/0000-0001-8989-7878)
- Dustin Stwalley (ORCID: https://orcid.org/0000-0002-6427-0590)
- Jacob C. Kahrs (ORCID: https://orcid.org/0000-0001-7171-2652)
- Michael J. Durkin (ORCID: https://orcid.org/0000-0003-4652-7089)
Institutions
- Rutgers, The State University of New Jersey (US)
- University of North Carolina at Chapel Hill (US)
- Kaiser Permanente Washington Health Research Institute (US)
- University of Washington (US)
- Washington University in St. Louis (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1002/pds.70115
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institute of Clinical and Translational Sciences
- Sarepta Therapeutics
- Astellas Pharma
- National Institutes of Health
- University of North Carolina at Chapel Hill
- AbbVie Canada
- National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development